Aziyo Biologics Inc Cl A (AZYO) |
|
14.64 -0.01 (-0.07%)
|
03-07 03:43 |
|
Open: |
14.65 |
Pre. Close: |
14.65 |
|
High:
|
14.75 |
Low:
|
14.52 |
|
Volume:
|
14,121 |
Market Cap:
|
150M |
|
|
|
|
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.846 - 14.989 |
14.989 - 15.075 |
|
Low:
|
14.213 - 14.402 |
14.402 - 14.516 |
|
Close:
|
14.424 - 14.731 |
14.731 - 14.916 |
|
Technical analysis |
as of: 2021-03-05 5:05:20 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 18.46 One year: 19.52 |
| Support: |
Support1: 14.34 Support2: 11.93 |
| Resistance: |
Resistance1: 15.81 Resistance2: 16.72 |
| Pivot: |
15.42  |
| Moving Average: |
MA(5): 15.00  MA(20): 15.47
MA(100): 13.65 MA(250): |
| MACD: |
MACD(12,26): -0.05 Signal(9): 0.12 |
| Stochastic oscillator: |
%K(14,3): 13.71 %D(3): 24.02 |
| RSI: |
RSI(14): 43.26 |
| 52-week: |
High: 18.20 Low: 10.55 Change(%): |
| Average Vol(K): |
3-Month: 2621 10-Days: 1255 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.AZYO has closed above bottom band by 5.1%. Bollinger Bands are 0% narrower than normal. |
|
|
Headline News |
Thu, 04 Mar 2021
FY2021 EPS Estimates for Aziyo Biologics, Inc. (NASDAQ:AZYO) Lowered by Analyst - MarketBeat
Mon, 01 Mar 2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
Mon, 01 Mar 2021
Edited Transcript of AZYO.OQ earnings conference call or presentation 1-Mar-21 9:30pm GMT - Yahoo Finance
Mon, 01 Mar 2021
Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results - Yahoo Finance
Wed, 17 Feb 2021
Aziyo Biologics Announces First Patient Enrolled in HEAL Study - GlobeNewswire
Wed, 17 Feb 2021
Aziyo Biologics (NASDAQ:AZYO) Lowered to "Hold" at Zacks Investment Research - MarketBeat
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
7 |
| Shares Float (M) |
2 |
|
% Held by Insiders
|
9.02 |
|
% Held by Institutions
|
59.88 |
|
Shares Short (K)
|
154 |
|
Shares Short P. Month (K)
|
200 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
-45.54 |
|
Operating Margin
|
-30.39 |
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
5.7 |
|
Gross Profit (p.s.)
|
2.788 |
|
Sales Per Share
|
5.962 |
|
EBITDA (p.s.)
|
-1.262 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-11 |
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
2.45 |
|
Price to Cash Flow
|
-9.58 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
